The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
FDA-Approved Oligonucleotide Therapies in 2017
Open accessAbstract
Oligonucleotides (oligos) have been under clinical development for approximately the past 30 years, beginning with antisense oligonucleotides (ASOs) and apatmers and followed about 15 years ago by siRNAs. During that lengthy period of time, numerous clinical trials have been performed and thousands of trial participants accrued onto studies. Of all the molecules evaluated as of January 2017, the regulatory authorities assessed that six provided clear clinical benefit in rigorously controlled trials. The story of these six is given in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Fibroblast growth factors, their receptors and signaling
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Biological Roles of Fibroblast Growth Factor-2*
Bikfalvi, A., Klein, S., Pintucci, G., & Rifkin, D. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0292 · Cited by 959
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Seghezzi, G., Patel, S., Ren, C. J., Gualandris, A., Pintucci, G., Robbins, E. S., Shapiro, R. L., Galloway, A. C., Rifkin, D. B., & Mignatti, P. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1659 · Cited by 860
Eteplirsen for the treatment of Duchenne muscular dystrophy
Mendell, J. R., Rodino‐Klapac, L. R., Sahenk, Z., Roush, K., Bird, L., Lowes, L. P., Alfano, L., Gomez, A. M., Lewis, S., Kota, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23982 · Cited by 817
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 664
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70211-x · Cited by 653
Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590
Mendell, J. R., Goemans, N., Lowes, L. P., Alfano, L. N., Berry, K., Shao, J., Kaye, E. M., Mercuri, E., & for the Eteplirsen Study Group and Telethon Foundation DMD Italian Network (2016) · Annals of Neurology · doi:10.1002/ana.24555 · Cited by 518
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
Baird, A., & Ling, N. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90292-0 · Cited by 411
Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.52 · Cited by 387
De Mesmaeker, A., Haener, R., Martin, P., & Moser, H. E. (1995) · Accounts of Chemical Research · doi:10.1021/ar00057a002 · Cited by 386
Richardson, P. G., Riches, M. L., Kernan, N. A., Brochstein, J. A., Mineishi, S., Termuhlen, A. M., Arai, S., Grupp, S. A., Guinan, E. C., Martin, P. L., et al. (2016) · Blood · doi:10.1182/blood-2015-10-676924 · Cited by 336
Apolipoprotein B: mRNA Editing, Lipoprotein Assembly, and Presecretory Degradation
Davidson, N. O., & Shelness, G. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.169 · Cited by 311
Stein, E. A., Dufour, R., Gagne, C., Gaudet, D., East, C., Donovan, J. M., Chin, W., Tribble, D. L., & McGowan, M. (2012) · Circulation · doi:10.1161/circulationaha.112.104125 · Cited by 301
Dignan, F. L., Wynn, R. F., Hadzic, N., Karani, J., Quaglia, A., Pagliuca, A., Veys, P., & Potter, M. N. (2013) · British Journal of Haematology · doi:10.1111/bjh.12558 · Cited by 295
Dalle, J.-H., & Giralt, S. A. (2016) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.09.024 · Cited by 292
Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease)
Fan, C. Q., & Crawford, J. M. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.10.002 · Cited by 274
Thomas, G. S., Cromwell, W. C., Ali, S., Chin, W., Flaim, J. D., & Davidson, M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.081 · Cited by 245
Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S., & Perera, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400492-jlr200 · Cited by 225
McGowan, M. P., Tardif, J.-C., Ceska, R., Burgess, L. J., Soran, H., Gouni-Berthold, I., Wagener, G., & Chasan-Taber, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049006 · Cited by 224
(2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01327-2 · Cited by 222
Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor
Jellinek, D., Green, L. S., Bell, C., & Janjic, N. (1994) · Biochemistry · doi:10.1021/bi00200a028 · Cited by 184
DeLeve, L. D., Ito, Y., Bethea, N. W., McCuskey, M. K., Wang, X., & McCuskey, R. S. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00526.2002 · Cited by 143
Sinusoidal obstruction syndrome
Valla, D. C., & Cazals-Hatem, D. L. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.01.006 · Cited by 134
The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets
Eaton, B. E. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80103-2 · Cited by 123
Jones, L. S., Yazzie, B., & Middaugh, C. R. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400008-mcp200 · Cited by 109
Defibrotide: Properties and clinical use of an old/new drug
Pescador, R., Capuzzi, L., Mantovani, M., Fulgenzi, A., & Ferrero, M. E. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.05.001 · Cited by 104
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
Robinson-Hamm, J. N., & Gersbach, C. A. (2016) · Human Genetics · doi:10.1007/s00439-016-1725-z · Cited by 82
Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist
Bianchi, G., Barone, D., Lanzarotti, E., Tettamanti, R., Porta, R., Moltrasio, D., Cedro, A., Salvetti, L., Mantovani, M., & Prino, G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90864-e · Cited by 78
Palomo, M., Mir, E., Rovira, M., Escolar, G., Carreras, E., & Díaz‐Ricart, M. (2016) · Blood · doi:10.1182/blood-2015-10-676114 · Cited by 71
Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice
Stein, C. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.188 · Cited by 67
Self-citationBenimetskaya, L., Wu, S., Voskresenskiy, A. M., Echart, C., Zhou, J., Shin, J., Iacobelli, M., Richardson, P. G. G., Ayyanar, K., & Stein, C. (2008) · Blood · doi:10.1182/blood-2008-04-149682 · Cited by 58
Self-citationBesseling, J., Sjouke, B., & Kastelein, J. J. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.011 · Cited by 47
Francischetti, I. M. B., Oliveira, C. J. F., Ostera, G. R., Yager, S. B., Debierre-Grockiego, F., Carregaro, V., Jaramillo-Gutierrez, G., Hume, J. C. C., Jiang, L., Moretz, S. E., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240291 · Cited by 32
VEGF Inhibition Study in Ocular Neovascularization (VISION): Second Year Efficacy Data
D’Amico, D. J. (2005) · Investigative Ophthalmology & Visual Science · Cited by 11
Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy
van Deutekom, J. C., de Kimpe, S. J., & Campion, G. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.04.001 · Cited by 9
Cited by
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13098 · Cited by 1,085
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 632
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
Metadata
- Authors
- Stein, C. A., & Castanotto, D.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 25
- Issue
- 5
- Pages
- 1069-1075
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2600519390
- Cited by
- 608
- References
- 46
- FWCI
- 34.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.